TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/05/2025
Voltar para busca
Dado oficial do USPTO
NOVAGO PROMOBILITY THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
24/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42, 44
Data de depósito
26/01/2018
Data de registro
28/01/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2020
Última transação
24/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Schlieren, CH
Examinador
LAVOIE, RYAN
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "NOVAGO" in green font above the wording "PROMOBILITY THERAPEUTICS" in black font. To the right of the wording is a stylized image comprised of a design of four gray lines
Titulares e representantes
Titulares
NovaGo Therapeutics AG
Representantes
Janice Housey
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical productsfor the regenerative treatment of disorders affecting human beingsincluding but not limited tocentral nervous systemeyeskin and other disorders; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposesbiological monoclonal antibodies and formulations for human therapeutic use; biological preparations for use in industry and science; peptides for chemical products and foodstuffs in the nature of biological monoclonal antibodies and formulations for human therapeutic use; polypeptides; antibodies and proteins for scientific use
Classe 5
Pharmaceutical preparationsfor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; veterinary preparationsfor the regenerative treatment of disordersincludingbut not limited tocentral nervous systemeyeskin and other; preparations for immunotherapeutic purposesfor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; products for the removal of tumorsnamely preparations for neurodegenerative diseasesbut not limited totraumatic brain injuryspinal cord injurystroke; immunogens for medical usefor the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; vaccinesantibodiesepitopes for pharmaceutical use; peptides for pharmaceutical purposes; sanitary preparations for medical use for the regenerative treatment of disorders affecting human beingsincludingbut not limited tocentral nervous systemeyeskin and other disorders; biological preparations for medical use for the treatment of neurologicalophthalmicskin disorders; biocides; diagnostic productsfor the development of new therapeutic agents; towels for hygiene purposessanitary towels; dietetic foods for medical use; dietetic beverages for medical use; protein antibodies for medical purposesfor the regenerative treatment of disordersincludingbut not limited tocentral nervous systemeyeskin and other disorders
Classe 42
Monitoring of degenerative and traumatic disorders affecting human beings for quality control purposes; Research in the field of regenerative treatment of degenerative or traumatic human disorders; medical research in the field of sanitary care; computer software designcomputer programming; design and development of computer hardware; software development; consultancy and provision of information relating to quality control of pharmaceutical preparationspreparations for regenerative treatment of human disorders; software maintenance
Classe 44
Medical services; medical services in the field of immunity; provision of medical information; medical examinationsassessments used for clinical research purposes ; dispensing of pharmaceuticals; nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care; veterinary assistance in the nature of veterinary servicesassessments and procedures that leads to novel pharmaceutical products; beauty salon services; care services for animalsnamely for the regenerative treatment of veterinary trauma disorders; hygienic care; consultancy and provision of information relating to the operationpreparationadministration and dosage of pharmaceutical preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2019
PUBO
PUBLISHED FOR OPPOSITION
12/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/09/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/08/2019
GNRT
NON-FINAL ACTION E-MAILED
27/08/2019
CNRT
NON-FINAL ACTION WRITTEN
27/08/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/08/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
16/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/07/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/07/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/07/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2019
GNRT
NON-FINAL ACTION E-MAILED
02/07/2019
CNRT
NON-FINAL ACTION WRITTEN
02/07/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/01/2019
GPRA
PRIORITY ACTION E-MAILED
10/01/2019
CPRA
PRIORITY ACTION WRITTEN
10/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2018
ALIE
ASSIGNED TO LIE
13/12/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/12/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
29/11/2018
GNSL
LETTER OF SUSPENSION E-MAILED
29/11/2018
CNSL
SUSPENSION LETTER WRITTEN
29/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/05/2018
GNRT
NON-FINAL ACTION E-MAILED
14/05/2018
CNRT
NON-FINAL ACTION WRITTEN
14/05/2018
DOCK
ASSIGNED TO EXAMINER
09/05/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/02/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2018
NWAP
NEW APPLICATION ENTERED
30/01/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVAGO PROMOBILITY THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.